China Medical System Holdings Limited
CHSYF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $3 |
| % Growth | 3.7% | 6.8% | 6.1% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $3 | $3 | $3 | $2 |
| % Margin | 72.3% | 70.7% | 74.7% | 72.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 20.8% | 23.4% | 23% | 24.7% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $0 |
| % Margin | 23.5% | 18.4% | 25.2% | 14.1% |
| EPS | 0.39 | 0.29 | 0.37 | 0.2 |
| % Growth | 34.5% | -21.6% | 85% | – |
| EPS Diluted | 0.39 | 0.29 | 0.37 | 0.2 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 23.5% | 35.4% | 26.1% | 27.8% |